Following the outstanding success of our recent £1.35m equity raise, StablePharma (www.stablepharma.com) is bringing a patented device to market that stands to significantly improve the way most vaccines are distributed globally, which will eliminate the current c. 50% wastage. Now, that we have our first clinical trials in humans underway, Stablepharma is delighted to announce […]
Read More